tiprankstipranks
Trending News
More News >
Sprint Bioscience AB (DE:5JA1)
:5JA1

Sprint Bioscience AB (5JA1) Price & Analysis

Compare
0 Followers

5JA1 Stock Chart & Stats


Financials

5JA1 FAQ

What was Sprint Bioscience AB’s price range in the past 12 months?
Sprint Bioscience AB lowest stock price was €0.02 and its highest was €0.17 in the past 12 months.
    What is Sprint Bioscience AB’s market cap?
    Sprint Bioscience AB’s market cap is €4.01M.
      When is Sprint Bioscience AB’s upcoming earnings report date?
      Sprint Bioscience AB’s upcoming earnings report date is Aug 27, 2025 which is in 80 days.
        How were Sprint Bioscience AB’s earnings last quarter?
        Sprint Bioscience AB released its earnings results on May 27, 2025. The company reported -€0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.007.
          Is Sprint Bioscience AB overvalued?
          According to Wall Street analysts Sprint Bioscience AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Sprint Bioscience AB pay dividends?
            Sprint Bioscience AB does not currently pay dividends.
            What is Sprint Bioscience AB’s EPS estimate?
            Sprint Bioscience AB’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Sprint Bioscience AB have?
            Sprint Bioscience AB has 105,515,540 shares outstanding.
              What happened to Sprint Bioscience AB’s price movement after its last earnings report?
              Sprint Bioscience AB reported an EPS of -€0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Sprint Bioscience AB?
                Currently, no hedge funds are holding shares in DE:5JA1

                Company Description

                Sprint Bioscience AB

                Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB (publ) was founded in 2009 and is based in Huddinge, Sweden.
                Similar Stocks
                Company
                Price & Change
                Follow
                Stayble Therapeutics AB
                Modus Therapeutics Holding AB
                ExpreS2ion Biotech Holding AB
                Spago Nanomedical AB
                CombiGene AB
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis